Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
September 30, 2026 2.155M
June 30, 2026 1.926M
March 31, 2026 1.922M
December 31, 2025 1.921M
September 30, 2025 1.919M
June 30, 2025 1.919M
March 31, 2025 38.34M
December 31, 2024 1.917M
September 30, 2024 38.27M
June 30, 2024 38.26M
March 31, 2024 38.13M
December 31, 2023 38.11M
September 30, 2023 37.97M
June 30, 2023 37.95M
March 31, 2023 37.81M
Date Value
December 31, 2022 37.80M
September 30, 2022 37.66M
June 30, 2022 37.64M
March 31, 2022 37.47M
December 31, 2021 37.40M
September 30, 2021 37.25M
June 30, 2021 37.19M
March 31, 2021 36.33M
December 31, 2020 36.25M
September 30, 2020 36.25M
June 30, 2020 35.10M
March 31, 2020 36.25M
December 31, 2019 35.10M
September 30, 2019 1.726M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Caribou Biosciences, Inc. 108.04M
Oncolytics Biotech, Inc. 132.21M
Sangamo Therapeutics, Inc. 414.27M
Sarepta Therapeutics, Inc. 107.23M
Anixa Biosciences, Inc. 34.58M